Antibiotic resistance of urinary pathogens in female general practice patients

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 4, 2005, Pages 256-261

  Hummers Pradier, Eva ^a,d   Koch, Matthias ^b   Ohse, Ann Marit ^a   Heizmann, Wolfgang R ^c   Kochen, Michael M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Medical Partnership Wagner   (Germany)

^c Inst for Microbiology/Infectiology   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; NITROFURANTOIN; QUINOLONE DERIVATIVE; TRIMETHOPRIM;

ADULT; AGED; AGING; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONFIDENCE INTERVAL; DIABETES MELLITUS; ESCHERICHIA COLI; FEMALE; GENERAL PRACTICE; GERMANY; HIGH RISK PATIENT; HUMAN; INDWELLING CATHETER; MAJOR CLINICAL STUDY; PATHOGENESIS; PREDICTION; PREVALENCE; PROTEUS; RISK ASSESSMENT; SPECIES DIFFERENCE; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; URINARY TRACT INFECTION; URINARY TRACT SURGERY; URINE CULTURE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIA; CHILD; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; GERMANY; HUMANS; MIDDLE AGED; ODDS RATIO; URINARY TRACT INFECTIONS;

EID: 17444366216     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410021009     Document Type: Article

References (49)

1. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:41-50.
2. Davey P, Steinke D, MacDonald T, Phillips G, Sullivan F. Not so simple cystitis: how should prescribers be supported to make informed decisions about the increasing prevalence of infections caused by drug-resistant bacteria? Br J Gen Pract 2000;50:143-6.
3. Stamm WE. An epidemic of urinary tract infections? N Engl J Med 2001;345:1055-7.
4. Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 2004;36:296-301.
5. Andre M, Molstad S, Lundborg CS, Odenholt I and the Swedish Study Group on Antibiotic Use. Management of urinary tract infections in primary care: a repeated 1-week diagnosis-prescribing study in 5 counties in Sweden in 2000 and 2002, Scand J Infect Dis 2004;36:134-8.
6. Kahlmeter G, ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project, J Antimicrob Chemother 2003;51:69-76.
7. Richards DA, Toop LJ, Chambers ST, Sutherland MG, Harris BH, Ikram RB, et al. Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories. N Z Med J 2002;115:12-4.
8. Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM. Urinary tract infections in men. Int J Clin Pharmacol Ther 2004;42:360-6.
9. Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM. Management of urinary tract infections in female general practice patients, Fam Pract 2005;22 [Epub. Jan. 7].
10. Stamm WE, Hooton TM. Management of urinary tract infection in adults. N Engl J Med 1993;329:1328-34.
11. Hummers-Pradier E, Kochen MM. Dysuria. DEGAM-guideline No. 1 (in German.) Zeitschrift für Allgemeinmedizin 2000;76:35-48.
12. Clarridge JE, Pezzlo MT, Vosti KL, Weissfeld AS. (coordinating ed.), Cumitech 2A, Laboratory diagnosis of urinary tract infections. American Society of Microbiology. Washington DC: 1987.
13. Anonymous. Medical Microbiology and Immunology: diagnostic procedures (in German), 3rd edn. Deutsches Institut für Normung e.V (German Institute for Standardisation). Berlin: 2000.
14. Bourbeau PP, Heiter BJ. Comparison of Vitek GNI and GNI+ Cards for identification of Gram-negative bacteria. J Clin Microbiol 1998;36:2775-7.
15. O'Hara CM, Westbrook GL, Miller JM. Evaluation of Vitek GNI+ and Becton-Dickinson Microbiology Systems Crystal E/NF identification systems for identification of members of the family Enterobacteriaceae and other Gram-negative, glucose-fermenting bacilli. J Clin Microbiol 1997;35:3269-73.
16. Ligozzi M, Bernini C, Bonora MG, De Fatima M, Zuliani J, Fontana R. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant Gram-positive cocci. J Clin Microbiol 2002;40: 1681-6.
17. Traub WH, Geipel U, Leonhard B. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media. Chemotherapy 1998;44:217-29.
18. Doern GV, Brueggemann AB, Perla R, Daly J, Halkias D, Jones RN, Saubolle MA. Multicentre laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol 1997;35:2115-9.
19. SAS Institute Inc. SAS/STAT. User's guide, Version 8, vol.3. 1999; Cary, NC: SAS Inst. Inc. http://www.sas.com/technologies/analytics/statistics/stat/ (accessed on November11, 2004)
20. Kunin CM, White LV, Hua TH. A reassessment of the importance of low-count bacteriuria in young women with acute urinary symptoms. Ann Intern Med 1993;119:454-60.
21. Burman WJ, Breese PE, Murray BE, Singh KV, Batal HA, MacKenzie TD, et al. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am J Med 2003;115:358-64.
22. Jureen R, Digranes A, Baerheim A. Urinary tract pathogens in uncomplicated lower urinary tract infections in women in Norway (in Norwegian.) Tidsskr Nor Laegeforen 2003; 123:2021-2.
23. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003;88:444-5.
24. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003;46:94-100.
25. Gulich M, Bux C, Zeitler HP. The DEGAM guidelines 'Dysuria' by the German Society of General Practice and Family Medicine (DEGAM): possible consequences of the implementation in general practice (in German.) Z Arztl Fortbild Qualitatssich 2001;95:141-5.
26. Hummers-Pradier E, Beyer M, Gerlach F, Kochen MM. A feasibility study as part of the development of guidelines for general practice in Germany. Eur J Gen Pract 2001;7:A6.
27. Bell-Syer SE, Moffett JA. Recruiting patients to randomized trials in primary care: principles and case study. Fam Pract 2000;17:187-91.
28. Wilson S, Delaney BC, Roalfe A, Roberts L, Redman V, Wearn AM, Hobbs FD. Randomized controlled trials in primary care: case study. Br Med J 2000;321:24-7.
29. Egidi G, Gebhardt K. Experiences with the guidelines for dysuria (in German.) Zeitschrift für Allgemeinmedizin 2003; 79:181-6.
30. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 2001;47:781-7.
31. Lawrenson RA, Logie JW. Antibiotic failure in the treatment of urinary tract infections in young women. J Antimicrob Chemother 2001;48:895-901.
32. Allen UD, MacDonald N, Fuite L, Chan F, Stephens D. Risk factors for resistance to 'first-line' antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 1999;160:1436-40.
33. Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 2002;34:1061-6.
34. Metlay JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 2003;51:963-70.
35. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infection. Ann Intern Med 2001;135:41-50.
36. Magee JT, Pritchard EL, Fitzgerald KA, Dunstan FD, Howard AJ. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8. Br Med J 1999;319:1239-40.
37. McIsaac WJ, Low DE, Biringer A, Pimlott N, Evans M, Glazier R. The impact of empirical management of acute cystitis on unnecessary antibiotic use. Arch Intern Med 2002;162:600-5.
38. Christiaens TC, Digranes A, Baerheim A. The relation between sale of antimicrobial drugs and antibiotic resistance in uropathogens in general practice. Scand J Prim Health Care 2002;20:45-9.
39. Bakken JS. The fluoroquinolones. How long will their utility last? Scand J Infect Dis 2004;36:85-92.
40. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000;46:223-8.
41. Lautenbach E, Larosa LA, Kasbekar N, Peng HP, Maniglia RJ, Fishman NO. Fluoroquinolone utilization in the emergency departments of academic medical centres: prevalence of, and risk factors for, inappropriate use. Arch Intern Med 2003;163:601-5.
42. PRODIGY. Urinary tract infection (lower) - women. Sowerby Centre for Health Informatics at Newcastle (cited 2004 Jun 27) available from URL. http://www.prodigy.nhs.uk/guidance.asp?gt=UTI%20(lower)%20-%20women
43. Timmermans AE, Baselier PJAM, Winkens RAG, Arets H, Wiersma TJ. NHG standard: urinary tract infection (in Dutch.) Huisarts en Wetenschap 1999;42:613-22.
44. Hummers-Pradier E, Kochen MM. Urinary tract infections in adult general practice patients. Br J Gen Pract 2002;52:752-61.
45. Flottorp S, Oxman AD, Cooper JG, Hjortdahl P, Sandberg S, Vorland LH. Guidelines for diagnosis and treatment of acute urinary tract problems in women (in Norwegian.) Tidsskr Nor Laegefor 2000;120:1748-53.
46. Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, et al and the Israeli Urinary Tract Infection Group. Empirical use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens, Clin Infect Dis 2002;34:1165-9.
47. Reeves DS. A perspective on the safety of antibacterials used to treat urinary tract infections. J Antimicrob Chemother 1994;33(Suppl A):111-20.
48. Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomized controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002;52:729-34.
49. Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 2002;162:41-7.